{"name":"Tigenix S.A.U.","slug":"tigenix-s-a-u","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Cx611","genericName":"Cx611","slug":"cx611","indication":"Other","status":"phase_1"},{"name":"Fibrin adhesive","genericName":"Fibrin adhesive","slug":"fibrin-adhesive","indication":"Surgical hemostasis and tissue adhesion","status":"phase_3"},{"name":"ASCs","genericName":"ASCs","slug":"ascs","indication":"Cartilage repair","status":"phase_2"},{"name":"CX501","genericName":"CX501","slug":"cx501","indication":"Duchenne muscular dystrophy","status":"phase_2"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"ASCs (Cx401, company code)","genericName":"ASCs (Cx401, company code)","slug":"ascs-cx401-company-code","indication":"Chronic diabetic foot ulcers","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Cx601","genericName":"Cx601","slug":"cx601","indication":"Complex perianal fistulas in patients with Crohn's disease","status":"phase_3"}]}],"pipeline":[{"name":"Cx611","genericName":"Cx611","slug":"cx611","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Fibrin adhesive","genericName":"Fibrin adhesive","slug":"fibrin-adhesive","phase":"phase_3","mechanism":"Fibrin adhesive acts as a biological glue that promotes hemostasis and tissue adhesion by mimicking the final stages of the coagulation cascade to form a stable fibrin clot.","indications":["Surgical hemostasis and tissue adhesion","Wound healing and tissue sealing in surgical applications"],"catalyst":""},{"name":"ASCs","genericName":"ASCs","slug":"ascs","phase":"phase_2","mechanism":"ASCs are autologous mesenchymal stem cells used to treat various conditions.","indications":["Cartilage repair","Orthopedic conditions"],"catalyst":""},{"name":"ASCs (Cx401, company code)","genericName":"ASCs (Cx401, company code)","slug":"ascs-cx401-company-code","phase":"phase_3","mechanism":"Cx401 is an allogeneic adipose-derived mesenchymal stem cell therapy that promotes tissue repair and reduces inflammation in chronic wounds.","indications":["Chronic diabetic foot ulcers"],"catalyst":""},{"name":"CX501","genericName":"CX501","slug":"cx501","phase":"phase_2","mechanism":"CX501 is a gene therapy that aims to increase the production of dystrophin in patients with Duchenne muscular dystrophy.","indications":["Duchenne muscular dystrophy"],"catalyst":""},{"name":"Cx601","genericName":"Cx601","slug":"cx601","phase":"phase_3","mechanism":"Cx601 is an allogeneic adipose-derived mesenchymal stem cell therapy that promotes tissue repair and immune modulation in the colon.","indications":["Complex perianal fistulas in patients with Crohn's disease"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":6,"phaseCounts":{"phase_1":1,"phase_3":3,"phase_2":2},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}